Monopar Therapeutics (MNPR) Misses Q3 EPS by 48c
Tweet
Share
E-mailGet Alerts MNPR Hot Sheet
Join SI Premium – FREE
Monopar Therapeutics (NASDAQ: MNPR) reported Q3 EPS of ($0.48).
For earnings history and earnings-related data on Monopar Therapeutics (MNPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Axis Capital Limited Upgrades Infosys Ltd. (INFO:IN) (INFY) to Buy (1)
- Berenberg Starts Barclays Plc (BARC:LN) (BCS) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
